Your browser doesn't support javascript.
loading
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI.
Vallejo-Vaz, Antonio J; Bray, Sarah; Villa, Guillermo; Brandts, Julia; Kiru, Gaia; Murphy, Jennifer; Banach, Maciej; De Servi, Stefano; Gaita, Dan; Gouni-Berthold, Ioanna; Kees Hovingh, G; Jozwiak, Jacek J; Jukema, J Wouter; Gabor Kiss, Robert; Kownator, Serge; Iversen, Helle K; Maher, Vincent; Masana, Luis; Parkhomenko, Alexander; Peeters, André; Clifford, Piers; Raslova, Katarina; Siostrzonek, Peter; Romeo, Stefano; Tousoulis, Dimitrios; Vlachopoulos, Charalambos; Vrablik, Michal; Catapano, Alberico L; Poulter, Neil R; Ray, Kausik K.
Afiliação
  • Vallejo-Vaz AJ; School of Public Health, Imperial College London, London, UK.
  • Bray S; Department of Medicine, Faculty of Medicine, University of Seville, Seville, Spain.
  • Villa G; Clinical Epidemiology and Vascular Risk, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/Universidad de Sevilla/CSIC, Seville, Spain.
  • Brandts J; Global Biostatistical Science, Amgen Ltd, Cambridge, UK.
  • Kiru G; Global Health Economics, Amgen Europe (GmbH), Rotkreuz, Switzerland.
  • Murphy J; Imperial Centre for Cardiovascular Disease Prevention Imperial Clinical Trials Unit, Department of Primary Care and Public Health, School of Public Health, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK.
  • Banach M; Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany.
  • De Servi S; Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Gaita D; Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Gouni-Berthold I; Department of Hypertension, Medical University of Lódz, Lódz, Poland.
  • Kees Hovingh G; Polish Mother's Memorial Hospital-Research Institute (PMMHRI), Lódz, Poland.
  • Jozwiak JJ; Cardiovascular Research Centre, University of Zielona Góra, Zielona Góra, Poland.
  • Jukema JW; IRCCS MultiMedica, Milan, Italy.
  • Gabor Kiss R; Institutul de Boli Cardiovasculare, Fundatia Cardioprevent, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
  • Kownator S; Centre for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Iversen HK; Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, Netherlands.
  • Maher V; Department of Family Medicine and Public Health, Faculty of Medicine, University of Opole, Opole, Poland.
  • Masana L; Leiden University Medical Center, Leiden, Netherlands.
  • Parkhomenko A; Hungarian Army Medical Center, Budapest, Hungary.
  • Peeters A; Centre Cardiologique et Vasculaire, Thionville, France.
  • Clifford P; Department of Neurology, Stroke Centre Rigshospitalet, Copenhagen, Rigshospitalet, Denmark.
  • Raslova K; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Siostrzonek P; Trinity College Dublin, Dublin, Ireland.
  • Romeo S; Advanced Lipid Management and Research Centre, Tallaght University Hospital, Dublin, Ireland.
  • Tousoulis D; Universitat Rovira I Virgili, IISPV, CIBERDEM, Saint Joan University Hospital, Reus, Spain.
  • Vlachopoulos C; Emergency Cardiology Department, Institute of Cardiology, Kiev, Ukraine.
  • Vrablik M; Cliniques Universitaires Saint Luc, Brussels, Belgium.
  • Catapano AL; Imperial Hospitals NHS Trust (Hammersmith Campus), London, UK.
  • Poulter NR; Slovak Medical University, Bratislava, Slovakia.
  • Ray KK; Krankenhaus Barmherzige Schwestern Linz, Linz, Austria.
Cardiovasc Drugs Ther ; 37(5): 941-953, 2023 10.
Article em En | MEDLINE | ID: mdl-35567726
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases / Aterosclerose Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Cardiovasc Drugs Ther Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases / Aterosclerose Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Cardiovasc Drugs Ther Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido